ClearPoint Neuro (CLPT) Gross Margin (2011 - 2026)
ClearPoint Neuro (CLPT) reported Gross Margin of 63.95% for Q1 2026, up 347.0% on a YoY basis from 14.31% in Q1 2025, and up 3.96% sequentially from 61.52% in Q4 2025.
ClearPoint Neuro (CLPT) Gross Margin (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Gross Margin data on file, last reported at 63.95% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 347.0% year-over-year to 63.95%; the trailing twelve-month figure through Mar 2026 stood at 62.33% (up 113.0% YoY), and the FY2025 full-year result was 61.38%, up 46.0% from the prior year.
- Gross Margin grew to 63.95% in Q1 2026, from 61.52% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 71.49% in Q3 2022 to a low of 52.54% in Q2 2023.
- A 5-year average of 61.39% and a median of 61.28% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin sank 1469 bps in 2023 and surged 1094 bps in 2024, its largest moves.
- Tracing CLPT's Gross Margin over 5 years: stood at 65.06% in 2022, then declined by 9 bps to 58.93% in 2023, then climbed by 4 bps to 61.28% in 2024, then climbed by 0 bps to 61.52% in 2025, then grew by 4 bps to 63.95% in 2026.
- Business Quant data shows CLPT's Gross Margin at 63.95% in Q1 2026, 61.52% in Q4 2025, and 63.2% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 63.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.95% |
| Dec 31, 2025 | 61.52% |
| Sep 30, 2025 | 63.20% |
| Jun 30, 2025 | 60.29% |
| Mar 31, 2025 | 60.48% |
| Dec 31, 2024 | 61.28% |
| Sep 30, 2024 | 59.68% |
| Jun 30, 2024 | 63.48% |
| Mar 31, 2024 | 59.24% |
| Dec 31, 2023 | 58.93% |
| Sep 30, 2023 | 56.80% |
| Jun 30, 2023 | 52.54% |
| Mar 31, 2023 | 58.94% |
| Dec 31, 2022 | 65.06% |
| Sep 30, 2022 | 71.49% |
| Jun 30, 2022 | 62.60% |
| Mar 31, 2022 | 64.22% |
| Dec 31, 2021 | 74.36% |
| Sep 30, 2021 | 66.48% |
| Jun 30, 2021 | 66.63% |